المؤلفون: Jacob. A., R. Sood, Kh. Victoria Chanu, Sandeep Bhatia, Rekha Khandia, A.K. Pateriya, S. Nagarajan, U. Dimri, D.D. Kulkarni

مصطلحات موضوعية: Amantadine, Antiviral resistance, Avian influenza, Matrix, India

العلاقة: Not Available; Jacob. A., R. Sood, Kh. Victoria Chanu, Sandeep Bhatia, Rekha Khandia, A.K. Pateriya, S. Nagarajan, U. Dimri, D.D. Kulkarni (2016). Amantadine resistance among highly pathogenic avian influenza viruses (H5N1) isolated from India. Microb Pathog. 2016 Feb;91:35-40; http://krishi.icar.gov.in/jspui/handle/123456789/6005Test

الإتاحة: http://krishi.icar.gov.in/jspui/handle/123456789/6005Test

مصطلحات الفهرس: Antiviral drugs, Coronavirs, COVID-19, Ecotoxicity, Persistance, resistance, Virus, Water, Aquatic organisms, Behavioral research, Binary alloys, Diseases, Metabolites, Sewage treatment plants, Uranium alloys, Wastewater treatment, Antiviral resistance, Climatic conditions, Environmental fate, Environmental occurrence, Fate and transport, Inactivation mechanisms, Transformation products, Wastewater treatment plants, Viruses, Infectious Medicine, Infektionsmedicin, Article in journal, info:eu-repo/semantics/article, text

URL: http://urn.kb.se/resolve?urn=urn:nbn:se:kth:diva-290603Test
Journal of Hazardous Materials, 0304-3894, 2021, 405

مصطلحات الفهرس: liver cirrhosis/dt [Drug Therapy], adult, alanine aminotransferase blood level, antiviral resistance, antiviral therapy, article, aspartate aminotransferase blood level, bile duct carcinoma/si [Side Effect], clinical assessment, controlled study, creatinine blood level, creatinine clearance, disease severity, double blind procedure, drug efficacy, drug fatality/si [Side Effect], drug safety, drug withdrawal, female, follow up, hepatitis B/dr [Drug Resistance], hepatitis B/dt [Drug Therapy], histopathology, human, kidney failure/si [Side Effect], lactate dehydrogenase blood level, liver biopsy, liver cell carcinoma/si [Side Effect], liver cirrhosis/di [Diagnosis], liver fibrosis/di [Diagnosis], liver fibrosis/dt [Drug Therapy], lung metastasis/si [Side Effect], major clinical study, male, nasopharynx carcinoma/si [Side Effect], open study, osteopenia/si [Side Effect], osteoporosis/si [Side Effect], phosphate blood level, priority journal, randomized controlled trial, remission, scoring system, seroconversion, side effect/si [Side Effect], treatment duration, uterine cervix cancer/si [Side Effect], virology, virus load, adefovir/cm [Drug Comparison], adefovir/dt [Drug Therapy], hepatitis B(e) antigen/ec [Endogenous Compound], tenofovir disoproxil/ae [Adverse Drug Reaction], tenofovir disoproxil/ct [Clinical Trial], tenofovir disoproxil/cm [Drug Comparison], tenofovir disoproxil/dt [Drug Therapy], face spasm/si [Side Effect], Ishak scoring system, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27324Test
The Lancet
Click here for full text options
LibKey Link

مصطلحات الفهرس: liver cirrhosis/dt [Drug Therapy], adult, alanine aminotransferase blood level, antiviral resistance, antiviral therapy, article, aspartate aminotransferase blood level, bile duct carcinoma/si [Side Effect], clinical assessment, controlled study, creatinine blood level, creatinine clearance, disease severity, double blind procedure, drug efficacy, drug fatality/si [Side Effect], drug safety, drug withdrawal, female, follow up, hepatitis B/dr [Drug Resistance], hepatitis B/dt [Drug Therapy], histopathology, human, kidney failure/si [Side Effect], lactate dehydrogenase blood level, liver biopsy, liver cell carcinoma/si [Side Effect], liver cirrhosis/di [Diagnosis], liver fibrosis/di [Diagnosis], liver fibrosis/dt [Drug Therapy], lung metastasis/si [Side Effect], major clinical study, male, nasopharynx carcinoma/si [Side Effect], open study, osteopenia/si [Side Effect], osteoporosis/si [Side Effect], phosphate blood level, priority journal, randomized controlled trial, remission, scoring system, seroconversion, side effect/si [Side Effect], treatment duration, uterine cervix cancer/si [Side Effect], virology, virus load, adefovir/cm [Drug Comparison], adefovir/dt [Drug Therapy], hepatitis B(e) antigen/ec [Endogenous Compound], tenofovir disoproxil/ae [Adverse Drug Reaction], tenofovir disoproxil/ct [Clinical Trial], tenofovir disoproxil/cm [Drug Comparison], tenofovir disoproxil/dt [Drug Therapy], face spasm/si [Side Effect], Ishak scoring system, Article

URL: https://repository.monashhealth.org/monashhealthjspui/handle/1/27324Test
The Lancet
LibKey Link